{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:29:06Z","timestamp":1794000546407,"version":"4.8.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R01NS074409"],"award-info":[{"award-number":["R01NS074409"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n              <jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute seizures are common in pediatric cerebral malaria (CM), but usual care with phenobarbital risks respiratory suppression. We undertook studies of enteral levetiracetam (eLVT) to evaluate pharmacokinetics (PK), safety and efficacy including an open-label, randomized controlled trial (RCT) comparing eLVT to phenobarbital.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Children 24\u201383\u2009months old with CM were enrolled in an eLVT dose-finding study starting with standard dose (40\u2009mg\/kg load, then 30\u2009mg\/kg Q12 hours) titrated upward until seizure freedom was attained in 75% of subjects.<\/jats:p>\n                <jats:p>The RCT that followed randomized children to eLVT vs. phenobarbital for acute seizures and compared the groups on minutes with seizures based upon continuous electroencephalogram. Due to safety concerns, midway through the study children allocated to phenobarbital received the drug only if they continued to have seizures (either clinically or electrographically) after benzodiazepine treatment. Secondary outcomes were treatment failure requiring cross over, coma duration and neurologic sequelae at discharge. PK and safety assessments were also undertaken.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 30 comatose CM children, eLVT was rapidly absorbed and well-tolerated. eLVT clearance was lower in patients with higher admission serum creatinine (SCr), but overall PK parameters were similar to prior pediatric PK studies. Within 4\u2009h of the first dose, 90% reached therapeutic levels (&gt;\u200920\u2009\u03bcg\/mL) and all were above 6\u2009\u03bcg\/mL. 7\/7 children achieved seizure freedom on the initial eLVT dose.<\/jats:p>\n                <jats:p>Comparing 23 eLVT to 21 phenobarbital patients among whom 15\/21 received phenobarbital, no differences were seen for minutes with seizure, seizure freedom, coma duration, neurologic sequelae or death, but eLVT was safer (<jats:italic>p<\/jats:italic>\u2009=\u20090.019). Phenobarbital was discontinued in 3\/15 due to respiratory side effects.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Enteral LVT offers an affordable option for seizure control in pediatric CM and is safer than phenobarbital.<\/jats:p>\n              <\/jats:sec>\n              <jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01660672\">NCT01660672<\/jats:ext-link>.<\/jats:p>\n                <jats:p><jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01988812\">NCT01982812<\/jats:ext-link>.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12887-019-1766-2","type":"journal-article","created":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T09:28:57Z","timestamp":1572600537000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["A clinical trial of enteral Levetiracetam for acute seizures in pediatric cerebral malaria"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0735-3461","authenticated-orcid":false,"given":"Gretchen L.","family":"Birbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan T.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmund V.","family":"Capparelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraction K.","family":"Dzinjalamala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samah G.","family":"Abdel Baki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macpherson","family":"Mallewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neema M.","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas G.","family":"Postels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph C.","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrie E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl B.","family":"Seydel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,1]]},"reference":[{"issue":"12","key":"1766_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1474-4422(05)70247-7","volume":"4","author":"R Idro","year":"2005","unstructured":"Idro R, Jenkins NE, Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol. 2005;4(12):827\u201340.","journal-title":"Lancet Neurol"},{"issue":"12","key":"1766_CR2","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S1474-4422(10)70270-2","volume":"9","author":"G Birbeck","year":"2010","unstructured":"Birbeck G, Molyneux M, Kaplan P, Seydel K, Chimalizeni Y, Kawaza K, Taylor T. The Blantyre malaria project epilepsy study (BMPES): neurologic outcomes in a prospective exposure-control study of retinopathy-positive pediatric cerebral malaria survivors. Lancet Neurol. 2010;9(12):1173\u201381.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1766_CR3","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1136\/jnnp.2004.043893","volume":"76","author":"JA Carter","year":"2005","unstructured":"Carter JA, Mung'ala-Odera V, Neville BG, Murira G, Mturi N, Musumba C, Newton CR. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J Neurol Neurosurg Psychiatry. 2005;76(4):476\u201381.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"1766_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1365-3156.2008.02076.x","volume":"13","author":"A Roca-Feltrer","year":"2008","unstructured":"Roca-Feltrer A, Carneiro I, Armstrong Schellenberg JR. Estimates of the burden of malaria morbidity in Africa in children under the age of 5 years. Tropical Med Int Health. 2008;13(6):771\u201383.","journal-title":"Tropical Med Int Health"},{"issue":"6","key":"1766_CR5","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1002\/ana.410430603","volume":"43","author":"CR Newton","year":"1998","unstructured":"Newton CR, Warrell DA. Neurological manifestations of falciparum malaria. Ann Neurol. 1998;43(6):695\u2013702.","journal-title":"Ann Neurol"},{"issue":"3","key":"1766_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/adc.84.3.247","volume":"84","author":"J Crawley","year":"2001","unstructured":"Crawley J, Smith S, Muthinji P, Marsh K, Kirkham F. Electroencephalographic and clinical features of cerebral malaria. Arch Dis Child. 2001;84(3):247\u201353.","journal-title":"Arch Dis Child"},{"issue":"2","key":"1766_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000475","volume":"2","author":"S Gwer","year":"2012","unstructured":"Gwer S, Thuo N, Idro R, Ndiritu M, Boga M, Newton C, Kirkham F. Changing trends in incidence and aetiology of childhood acute non-traumatic coma over a period of changing malaria transmission in rural coastal Kenya: a retrospective analysis. BMJ Open. 2012;2(2):e000475.","journal-title":"BMJ Open"},{"issue":"9205","key":"1766_CR8","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0140-6736(99)07148-2","volume":"355","author":"J Crawley","year":"2000","unstructured":"Crawley J, Waruiru C, Mithwani S, Mwangi I, Watkins W, Ouma D, Winstanley P, Peto T, Marsh K. Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study. Lancet. 2000;355(9205):701\u20136.","journal-title":"Lancet"},{"key":"1766_CR9","unstructured":"World Health Organization: Updated guideline: paediatric emergency triage, assessment and treatment. Geneva: World Health Organization; 2016. \n                    https:\/\/apps.who.int\/iris\/handle\/10665\/204463\n                    \n                   Accessed 4August2019."},{"issue":"11","key":"1766_CR10","doi-asserted-by":"publisher","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","volume":"43","author":"PN Patsalos","year":"2004","unstructured":"Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 2004;43(11):707\u201324.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"1766_CR11","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1056\/NEJMoa1400116","volume":"372","author":"KB Seydel","year":"2015","unstructured":"Seydel KB, Kampondeni SD, Valim C, Potchen MJ, Milner DA, Muwalo FW, Birbeck GL, Bradley WG, Fox LL, Glover SJ, et al. Brain swelling and death in children with cerebral malaria. N Engl J Med. 2015;372(12):1126\u201337.","journal-title":"N Engl J Med"},{"issue":"265","key":"1766_CR12","first-page":"441","volume":"71","author":"ME Molyneux","year":"1989","unstructured":"Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med. 1989;71(265):441\u201359.","journal-title":"Q J Med"},{"issue":"2","key":"1766_CR13","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0035-9203(97)90207-8","volume":"91","author":"CR Newton","year":"1997","unstructured":"Newton CR, Chokwe T, Schellenberg JA, Winstanley PA, Forster D, Peshu N, Kirkham FJ, Marsh K. Coma scales for children with severe falciparum malaria. Trans R Soc Trop Med Hyg. 1997;91(2):161\u20135.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"1766_CR14","volume-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva: World Health Organization; 2010.","edition":"2"},{"issue":"2","key":"1766_CR15","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/00007691-199604000-00008","volume":"18","author":"N Ratnaraj","year":"1996","unstructured":"Ratnaraj N, Doheny HC, Patsalos PN. A micromethod for the determination of the new antiepileptic drug levetiracetam (ucb LO59) in serum or plasma by high performance liquid chromatography. Ther Drug Monit. 1996;18(2):154\u20137.","journal-title":"Ther Drug Monit"},{"issue":"9","key":"1766_CR16","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/jps.23574","volume":"102","author":"N Holford","year":"2013","unstructured":"Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013;102(9):2941\u201352.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1766_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","volume":"30","author":"LJ Hirsch","year":"2013","unstructured":"Hirsch LJ, LaRoche SM, Gaspard N, Gerard E, Svoronos A, Herman ST, Mani R, Arif H, Jette N, Minazad Y, et al. American clinical neurophysiology Society's standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30(1):1\u201327.","journal-title":"J Clin Neurophysiol"},{"key":"1766_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/0471445428","volume-title":"Statistical methods for rates and proportions","author":"J Fleiss","year":"2003","unstructured":"Fleiss J, Levin B, Paik M. Statistical methods for rates and proportions. 3rd ed. New York, NY: Wiley-Interscience; 2003.","edition":"3"},{"key":"1766_CR19","volume-title":"The Power Procedure. In","author":"SAS\/STAT User's Guide","year":"2010","unstructured":"SAS\/STAT User's Guide. The Power Procedure. In. 9.2 ed. Cary, NC: SAS Institute Inc; 2010.","edition":"9.2"},{"issue":"Suppl 1","key":"1766_CR20","first-page":"S45","volume":"5","author":"TA Glauser","year":"2003","unstructured":"Glauser TA, Dulac O. Preliminary efficacy of levetiracetam in children. Epileptic Disord. 2003;5(Suppl 1):S45\u201350.","journal-title":"Epileptic Disord"},{"issue":"10","key":"1766_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","volume":"56","author":"E Trinka","year":"2015","unstructured":"Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, Shorvon S, Lowenstein DH. A definition and classification of status epilepticus--report of the ILAE task force on classification of status Epilepticus. Epilepsia. 2015;56(10):1515\u201323.","journal-title":"Epilepsia"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1766-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1766-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,31]],"date-time":"2020-10-31T00:27:03Z","timestamp":1604104023000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1766-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1766"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1766-2","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,1]]},"assertion":[{"value":"14 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from the parent or guardian prior to enrollment. This study was approved by the Research Ethics Committees at the University of Malawi (FWA00011868), Michigan State University (FWA00004556) and the University of Rochester (FWA00009386).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest relevant to this article to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"399"}}